BioAsia has announced that the Make in India initiative by Government of India has partnered with the 13th edition of BioAsia to be held in Hyderabad from 8th to 10th February 2016. The partnership will make BioAsia the only BioPharma event to associate with this ambitious initiative of the Government of India. ‘Make in India’ partnership will also enhance the level of the impact of the deliberations at the event, given that the relevant policy makers will be attendance at the event, to interact and engage with the industry and academic stakeholder.
India is among the countries considered as likely to have the strongest gains in developing next generation life-saving products in the coming decade. Recognizing this opportunity and rightly so, Government of India through its ‘Make in India’ initiative has attached ample emphasis on the pharmaceuticals and biotechnology sectors to fortify the country manufacturing ecosystem, to enhance development of skills, nurture a conducive regulatory environment, foster innovation and protect intellectual property. The initiative aims to encourage not only global companies to invest in India, but also enliven domestic players to increase their size. Complementing the Make in India initiative is the Telangana Government’s first-of-its-kind Pharma City, spread across 15,000 acres and at par with international standards.
Under this context, CEO Conclave of this edition of BioAsia will focus on “Make in India - Flavors of policy change”. The conclave will elicit thought provoking discussions on the opportunities and challenges for the sector under the Make in India program, besides proposing various policy measures that can accelerate the growth of life sciences sector in India.
Prominent industry leaders and policy makers including the likes of Dr. VK Subburaj, IAS, Secretary to GoI, Department of Pharmaceuticals, Mr. Rogerio Ribeiro, SVP & Head, Emerging Markets, GSK, Mr. RanjitShahani, Vice Chairman & Managing Director, Novartis India Limited, Dr. Pankaj Bhai Patel, Chairman, ZydusCadila, Dr. RenuSwarup, Managing Director, BIRAC-GoI; among others will participate in the conclave. The event will also see the unveiling of BioAsia-KPMG thought leadership report on Make in India for the biotech sector.
Mr. Shakthi Nagappan, CEO - BioAsia while commenting on the partnership with Make in India, said, “Make in India’s partnership with BioAsia is a testimony to the value that BioAsia has created for the life sciences industry over the last 12 years. We are sure that focused sessions around Make in India at BioAsia 2016 will add immense value to the all participants especially the pharma and biotech manufacturers”
This widely attended annual international convention will be organized by the Industries & Commerce Department, Government of Telangana, Federation of Asian Biotech Associations and the Pharmaceutical Export Promotion Council, Government of India. KPMG in India will be the knowledge partner for the event. In the last 12 editions of BioAsia has successfully organized over 12,000 B2B, B2R and R2R meetings. It has also facilitated and assisted in signing of over 200 LoI, bilateral cooperation agreement and MoUs.
